In a world first, researchers have mapped the cellular dynamics following treatment with the most commonly used advanced ...

Oxford researchers have discovered why some patients benefit from the most commonly used advanced therapy in autoimmune diseases and some do not.

SonoThera to Present at ASN Kidney Week 2024 Demonstrating the Potential of Novel Nonviral Ultrasound-Mediated Gene Therapy ...

Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...

Triple-negative breast cancer (TNBC): The breast tissue lacks estrogen receptors, progesterone receptors, and HER2 protein receptors that control how cells grow and divide. Triple-negative breast ...

As Canadians brace for "vitamin D winter"—months when the sun's angle is too low to produce the vitamin in the skin—a McGill ...

Foresee Pharma announces preliminary results from phase 1 trial, highlighting promising safety, tolerability and PK profile of linvemastat: Taipei, Taiwan Tuesday, October 22, 202 ...

(Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug discovery, today announced it has fully acquired Phenocell SAS, a pioneer in iPSC-based products and bioassays for ...

ADRX-0405 is a novel antibody-drug conjugate targeting STEAP1, and a phase 1a/b study will investigate the agent for the ...

Innovations in biotechnology are driving the engineering of tubular organs, providing functional replacements and improving ...